NuvOx Pharma

NuvOx Pharma, founded in Tucson, Arizona, is a pharmaceutical company dedicated to developing oxygen-delivering drugs aimed at reversing hypoxia. The company's core mission is to address the lack of oxygen in the body's cells, which is a critical factor in numerous fatal diseases. NuvOx's platform involves intravenous drugs that travel through the bloodstream to the lungs to pick up oxygen and deliver it to hypoxic tissues. Their primary focus areas include treatments for stroke, oncology, and sickle cell crisis, with several drugs in Phase II and Phase Ib trials.

Notable affiliated individuals and investors include experts in medical research and pharmaceutical development, although specific names are not provided. NuvOx Pharma has achieved significant milestones, such as advancing their drug candidates to Phase II and Phase Ib clinical trials. Their innovative approach to treating hypoxia has the potential to impact various medical fields significantly, offering new hope for patients suffering from conditions like stroke, cancer, and sickle cell disease.